SVB Securities downgraded Selecta Biosciences to Market Perform from Outperform with a $1 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SELB:
- Selecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiative Designed to Maximize Stockholder Value Associated with SEL-212 Economics
- Selecta Biosciences expects cash to fund operations into 2027
- Selecta Biosciences reports Q2 EPS (7c), consensus (8c)
- SELB Earnings this Week: How Will it Perform?
